Institutional Ownership Supernus Pharmaceuticals, Inc. (SUPN)
This table provides information about the institutional ownership of Supernus Pharmaceuticals, Inc. (SUPN). We have compiled data on the 303 institutions that hold shares in the stock, with a total of 60.6 Million shares, which have been reported (via 13F filing form) to have a value of $1.92 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,392,636
shares
|
$333 Million
0.01% of portfolio
|
Q2 2024
Added 0.29%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
6,150,759
shares
|
$197 Million
0.0% of portfolio
|
Q4 2024
Added 0.37%
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
4,836,000
shares
|
$155 Million
2.47% of portfolio
|
Q4 2024
Reduced 5.1%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
2,878,545
shares
|
$92.3 Million
0.03% of portfolio
|
Q4 2024
Reduced 0.14%
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
2,628,907
shares
|
$84.3 Million
0.11% of portfolio
|
Q4 2024
Reduced 0.11%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,188,205
shares
|
$70.2 Million
0.0% of portfolio
|
Q4 2024
Added 1.47%
|
|
Stephens Investment Management Group LLC
|
Jan 28, 2025 Q4 2024 |
1,752,068
shares
|
$56.2 Million
0.88% of portfolio
|
Q4 2024
Reduced 9.32%
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
1,687,930
shares
|
$54.1 Million
0.38% of portfolio
|
Q4 2024
Reduced 12.9%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,598,722
shares
|
$51.3 Million
0.09% of portfolio
|
Q4 2024
Reduced 7.51%
|
|
Pacer Advisors, Inc.
Malvern, PA |
Jan 22, 2025 Q4 2024 |
1,597,456
shares
|
$51.2 Million
0.14% of portfolio
|
Q4 2024
Reduced 8.87%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,510,568
shares
|
$48.4 Million
0.0% of portfolio
|
Q4 2024
Added 1.92%
|
|
Loomis Sayles & CO L P
|
Feb 12, 2025 Q4 2024 |
1,467,027
shares
|
$47 Million
0.07% of portfolio
|
Q4 2024
Reduced 3.24%
|
|
Gw&K Investment Management, LLC
Boston, MA |
Feb 05, 2025 Q4 2024 |
1,206,350
shares
|
$38.7 Million
0.37% of portfolio
|
Q4 2024
Reduced 2.56%
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
1,140,705
shares
|
$36.6 Million
0.02% of portfolio
|
Q4 2024
Added 9.17%
|
|
Aristotle Capital Boston, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,075,868
shares
|
$34.5 Million
1.48% of portfolio
|
Q4 2024
Reduced 9.91%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
933,952
shares
|
$29.9 Million
0.01% of portfolio
|
Q4 2024
Added 3.81%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
777,962
shares
|
$24.9 Million
0.03% of portfolio
|
Q2 2023
Added 27.31%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
753,363
shares
|
$24.2 Million
0.01% of portfolio
|
Q4 2024
Added 5.75%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
717,161
shares
|
$23 Million
0.0% of portfolio
|
Q4 2024
Added 18.29%
|
|
Victory Capital Management Inc
|
Feb 06, 2025 Q4 2024 |
714,321
shares
|
$22.9 Million
0.03% of portfolio
|
Q4 2024
Reduced 3.84%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
677,667
shares
|
$21.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 6.67%
|
|
Ashford Capital Management Inc
Wilmington, DE |
Feb 14, 2025 Q4 2024 |
545,775
shares
|
$17.5 Million
2.58% of portfolio
|
Q4 2024
Added 0.32%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
545,658
shares
|
$17.5 Million
0.02% of portfolio
|
Q4 2024
Added 33.48%
|
|
Rice Hall James & Associates, LLC
|
Jan 31, 2025 Q4 2024 |
528,345
shares
|
$16.9 Million
1.15% of portfolio
|
Q4 2024
Reduced 2.3%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
526,252
shares
|
$16.9 Million
0.02% of portfolio
|
Q4 2024
Reduced 6.13%
|